• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于表型组学发现新型变构胆碱激酶抑制剂

Phenomics-Based Discovery of Novel Orthosteric Choline Kinase Inhibitors.

作者信息

Bauer Ludwig G, Ward Jennifer A, Díaz-Sáez Laura, Sundström Yvonne, Tolvanen Tuomas, Alarcón Barrera Juan Carlos, Kostidis Sarantos, Rogers Catherine M, Panagakou Ioanna, Singh Usha, Rothweiler Elisabeth M, Gonzalez Orta Alejandro, Kaniskan H Ümit, Hu Jianping, Jin Jian, Sievers Sonja, Waldmann Herbert, Giera Martin, Sundström Michael, Berg Louise, Huber Kilian V M

机构信息

Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

出版信息

Angew Chem Int Ed Engl. 2025 Feb 10;64(7):e202420149. doi: 10.1002/anie.202420149. Epub 2025 Jan 13.

DOI:10.1002/anie.202420149
PMID:39740997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11811597/
Abstract

Choline kinase alpha (CHKA) is a central mediator of cell metabolism linked to cancer and immune regulation. Cellular and clinical evaluation of CHKA has been hampered by challenges in the development of drug-like choline kinase inhibitors. Here, we identify CHKA as an unexpected off-target of histone methyltransferase inhibitors using an integrated phenomic approach. We confirm CHKA as a direct protein target of the aminoquinazolines UNC0638 and UNC0737 using a combination of chemoproteomic, biochemical, cellular, and metabolic profiling assays, possibly explaining the previously reported discrepancies observed for different G9a/GLP inhibitor scaffolds in cellular assays. Using primary human cell model systems, we discover that CHKA modulation impairs IgG secretion and B-cell maturation consistent with the notion that choline metabolism plays an important role in immune signalling. Co-crystal structures of UNC0638 and UNC0737 with CHKA unravel an unexpected binding mode and suggest the inhibitors as attractive starting points for the development of selective chemical tools to further explore the biological role of CHKA in cancer and immune metabolism.

摘要

胆碱激酶α(CHKA)是细胞代谢的核心调节因子,与癌症和免疫调节相关。由于类药物胆碱激酶抑制剂开发面临挑战,CHKA的细胞和临床评估受到阻碍。在此,我们使用整合表型组学方法,将CHKA鉴定为组蛋白甲基转移酶抑制剂意外的脱靶蛋白。我们通过化学蛋白质组学、生化、细胞和代谢谱分析相结合的方法,确认CHKA是氨基喹唑啉类化合物UNC0638和UNC0737的直接蛋白质靶点,这可能解释了之前在细胞实验中观察到的不同G9a/GLP抑制剂支架的差异。使用原代人类细胞模型系统,我们发现CHKA调节会损害IgG分泌和B细胞成熟,这与胆碱代谢在免疫信号传导中起重要作用的观点一致。UNC0638和UNC0737与CHKA的共晶体结构揭示了一种意外的结合模式,并表明这些抑制剂是开发选择性化学工具以进一步探索CHKA在癌症和免疫代谢中的生物学作用的有吸引力的起点。

相似文献

1
Phenomics-Based Discovery of Novel Orthosteric Choline Kinase Inhibitors.基于表型组学发现新型变构胆碱激酶抑制剂
Angew Chem Int Ed Engl. 2025 Feb 10;64(7):e202420149. doi: 10.1002/anie.202420149. Epub 2025 Jan 13.
2
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.胆碱激酶α作为雄激素受体伴侣蛋白和前列腺癌治疗靶点
J Natl Cancer Inst. 2015 Dec 11;108(5). doi: 10.1093/jnci/djv371. Print 2016 May.
3
Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.胆碱激酶α介导肝癌细胞中表皮生长因子受体与雷帕霉素复合物2的机制性靶点之间的相互作用,以促进耐药性和异种移植肿瘤进展。
Gastroenterology. 2017 Apr;152(5):1187-1202. doi: 10.1053/j.gastro.2016.12.033. Epub 2017 Jan 5.
4
Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.发现组蛋白赖氨酸甲基转移酶 G9a 和 GLP 的体内化学探针。
J Med Chem. 2013 Nov 14;56(21):8931-42. doi: 10.1021/jm401480r. Epub 2013 Oct 31.
5
Identification of unprecedented ATP-competitive choline kinase inhibitors.鉴定前所未有的 ATP 竞争性胆碱激酶抑制剂。
Bioorg Med Chem Lett. 2021 Nov 1;51:128310. doi: 10.1016/j.bmcl.2021.128310. Epub 2021 Aug 18.
6
Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.胆碱激酶 α、表皮生长因子受体和 c-Src 在乳腺癌细胞增殖中的功能相互作用。
Oncogene. 2012 Mar 15;31(11):1431-41. doi: 10.1038/onc.2011.332. Epub 2011 Aug 8.
7
The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.新型胆碱激酶抑制剂ICL-CCIC-0019可重编程细胞代谢并抑制癌细胞生长。
Oncotarget. 2016 Jun 14;7(24):37103-37120. doi: 10.18632/oncotarget.9466.
8
Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis.胆碱激酶α基因(磷脂酰胆碱生物合成中的首个酶)的破坏导致早期胚胎致死。
J Biol Chem. 2008 Jan 18;283(3):1456-1462. doi: 10.1074/jbc.M708766200. Epub 2007 Nov 19.
9
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.胆碱激酶-α通过调节细胞侵袭性和药物敏感性成为卵巢癌潜在的可药物治疗靶点。
Br J Cancer. 2014 Jan 21;110(2):330-40. doi: 10.1038/bjc.2013.729. Epub 2013 Nov 26.
10
Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.G9a样蛋白(GLP)抑制剂的构效关系研究。
Bioorg Med Chem. 2017 Aug 15;25(16):4414-4423. doi: 10.1016/j.bmc.2017.06.021. Epub 2017 Jun 19.

本文引用的文献

1
Proteomics-Based Discovery of First-in-Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2).基于蛋白质组学的新型细胞程序性死亡蛋白 2(PDCD2)化学探针的发现。
Angew Chem Int Ed Engl. 2023 Oct 23;62(43):e202308292. doi: 10.1002/anie.202308292. Epub 2023 Sep 15.
2
Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research.系统文献回顾揭示了细胞生物医学研究中化学探针的使用不理想。
Nat Commun. 2023 Jun 3;14(1):3228. doi: 10.1038/s41467-023-38952-1.
3
Open resources for chemical probes and their implications for future drug discovery.
化学探针的开放资源及其对未来药物发现的影响。
Expert Opin Drug Discov. 2023 May;18(5):505-513. doi: 10.1080/17460441.2023.2199979. Epub 2023 Apr 16.
4
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use.化学探针门户:一个基于专家评审的公共资源,旨在增强化学探针评估、选择和使用的能力。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1492-D1502. doi: 10.1093/nar/gkac909.
5
Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2.针对EHMT1/2上游调节因子和相互作用分子的潜在治疗方法。
Cancers (Basel). 2022 Jun 9;14(12):2855. doi: 10.3390/cancers14122855.
6
The emerging role of mass spectrometry-based proteomics in drug discovery.基于质谱的蛋白质组学在药物发现中的新作用。
Nat Rev Drug Discov. 2022 Sep;21(9):637-654. doi: 10.1038/s41573-022-00409-3. Epub 2022 Mar 29.
7
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.PRIDE 数据库资源在 2022 年:一个基于质谱的蛋白质组学证据的中心。
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552. doi: 10.1093/nar/gkab1038.
8
Identification of unprecedented ATP-competitive choline kinase inhibitors.鉴定前所未有的 ATP 竞争性胆碱激酶抑制剂。
Bioorg Med Chem Lett. 2021 Nov 1;51:128310. doi: 10.1016/j.bmcl.2021.128310. Epub 2021 Aug 18.
9
Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay.通过在患者来源的细胞测定中筛选化学探针,鉴定慢性炎症性自身免疫性疾病的新型 B 细胞靶标。
Transl Res. 2021 Mar;229:69-82. doi: 10.1016/j.trsl.2020.09.003. Epub 2020 Sep 22.
10
Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production.胆碱摄取和代谢调节巨噬细胞 IL-1β 和 IL-18 的产生。
Cell Metab. 2019 Jun 4;29(6):1350-1362.e7. doi: 10.1016/j.cmet.2019.03.011. Epub 2019 Apr 11.